Nail Dystrophy Treatment 2026: Causes & Options | DPM

Nail Dystrophy Type	Appearance	Associated Condition	Key Finding	Treatment
Onychomycosis	Yellow-brown, thick, crumbling, subungual debris	Trichophyton rubrum most common	KOH+ / culture+	Oral terbinafine 12 weeks; laser
Trachyonychia (twenty-nail)	Longitudinal ridging, rough sandpaper surface, all nails	Alopecia areata, psoriasis, lichen planus	All 20 nails; nail biopsy	Intralesional triamcinolone; retinoids; observe if mild
Psoriatic nail dystrophy	Pitting, oil-drop sign, onycholysis, hyperkeratosis	Psoriasis ± PsA	Skin psoriasis elsewhere; pitting pathognomonic	Potent topical steroids; biologics (IL-17/TNF)
Lichen planus	Ridging, thinning, pterygium (adhesion), scarring	Oral/skin LP	Biopsy: saw-tooth rete ridges	Intralesional/systemic steroids; early intervention critical
Traumatic dystrophy	Ridges, split, thickening, leukonychia — single nail	Trauma, tight shoes	History + single nail affected	Proper footwear; allow nail to grow out 6–12 months
Chemo-induced	Beau’s lines, onycholysis, diffuse discoloration	Taxanes, anthracyclines, targeted therapy	Temporal relation to drug	Frozen gloves/socks during infusion; resolve post-chemo

Treatment	Best For	Mechanism	Evidence	Notes
Oral terbinafine 250mg × 12 wks	Fungal dystrophy	Squalene epoxidase inhibitor	Strong	Check LFTs; most effective for dermatophyte
Intralesional triamcinolone (nail matrix)	Trachyonychia, psoriasis, LP	Local anti-inflammatory	Strong (for nail matrix disease)	Multiple injections per nail; painful — digital block
Clobetasol 0.05% under occlusion	Psoriatic, LP	Potent topical corticosteroid	Moderate	Apply to proximal nail fold; occlusion enhances penetration
Tazarotene (retinoid) topical	Trachyonychia, psoriasis	Normalize nail matrix differentiation	Moderate	Irritation risk; apply sparingly
Biotin 2.5mg/day	Brittle nail syndrome, mild dystrophy	Cofactor for keratin synthesis	Low (limited RCT data)	Widely used; safe; interferes with thyroid lab assays
Laser (1064nm Nd:YAG)	Fungal dystrophy	Photothermal fungicidal	Moderate	No drug interactions; not covered by insurance

Related Conditions

Nail dystrophy is one of those conditions that patients often live with for years before seeking care — partly because it seems cosmetic, and partly because they assume nothing can be done about it. In reality, abnormal nails almost always have a specific, treatable underlying cause. Getting that diagnosis right is the difference between months of ineffective treatment and a nail that actually grows back normally. In our podiatry practice, we see nail dystrophy daily, and the range of causes is wider than most patients expect.

What Is Nail Dystrophy

• View on Amazon
• View on Amazon
• View on Amazon

Nail dystrophy refers to any structural abnormality of the nail unit — including the nail plate, nail bed, nail matrix, or surrounding skin — that results in changes to the nail’s shape, texture, color, thickness, or attachment. The term is descriptive rather than diagnostic: it tells you the nail is abnormal, but not why. From a clinical standpoint, nail dystrophy can affect one nail (focal disease) or multiple nails (systemic disease) and may progress over months to years if the underlying cause is untreated. The nail matrix — the tissue under the proximal nail fold responsible for generating new nail — is the key structure. Damage to the matrix produces permanent changes in the emerging nail plate.

Causes and Classification

Nail dystrophy has over a dozen distinct causes. We organize them into four categories to guide the diagnostic workup and treatment approach. Understanding which category a patient’s dystrophy falls into eliminates years of misdirected treatment.

Onychomycosis (Fungal Nail Dystrophy)

Onychomycosis accounts for roughly 50% of all nail dystrophy presentations in podiatry. Dermatophytes (most commonly Trichophyton rubrum) invade the nail plate through the distal or lateral groove, causing progressive discoloration (yellow-white-brown), thickening, onycholysis (nail separation from the bed), and subungual debris accumulation. It rarely resolves without treatment and can spread to adjacent nails and skin. Crucially, onychomycosis cannot be reliably diagnosed by appearance alone — studies show clinical diagnosis is accurate only about 50% of the time. Culture or PCR testing is necessary to confirm the fungus and guide antifungal selection. Read our full Toenail Fungus Treatment Guide →

Psoriatic Nail Dystrophy

Psoriasis affects the nails in 50–80% of people with cutaneous psoriasis, and nail involvement is present in up to 90% of those with psoriatic arthritis. Nail psoriasis produces a distinctive constellation: pitting (small depressions in the nail surface), oil-drop or salmon-patch discoloration under the nail, onycholysis, subungual hyperkeratosis, and nail bed erythema. Nail psoriasis is frequently misdiagnosed as onychomycosis — and antifungal treatment will obviously fail if psoriasis is the real cause. The presence of multiple nail types of changes across several nails, personal or family history of psoriasis, and concurrent joint symptoms point toward the correct diagnosis. Read our full Nail Psoriasis Treatment Guide →

Traumatic Nail Dystrophy

Repetitive microtrauma is the most underappreciated cause of nail dystrophy in active patients. Runners who log high mileage in shoes that are too small or too large sustain repeated impact of the great complete toenail problems guide against the toe box — over months, this damages the matrix and produces permanent dystrophic changes. The result can look identical to fungal infection: thickened, discolored, partially separated nail. But antifungals won’t help because there’s no infection. The fix is proper shoe fit (a thumb’s width of space beyond the longest toe), moisture-wicking socks, and in severe cases, nail avulsion to allow regrowth from an undamaged matrix.

Lichen Planus

Nail lichen planus is a less common but clinically significant cause of nail dystrophy that can produce permanent nail loss (pterygium — scarring that fuses the nail fold to the nail bed) if untreated. It produces thinning, longitudinal ridging, splitting, and in severe cases complete destruction of the nail plate. Diagnosis often requires nail biopsy. Treatment involves potent topical or intralesional corticosteroids and, in severe cases, systemic immunosuppression. Early treatment is critical — once pterygium has formed, regrowth is impossible.

Clinical Features and Diagnosis

The specific pattern of nail changes provides the most important diagnostic clues. In our clinic, we conduct a systematic nail unit examination — assessing the plate, bed, matrix zone, lateral folds, and hyponychium — and correlate findings with the patient’s medical history, medication list, and activity level. The following changes and their most likely associations guide our differential:

Diagnostic confirmation typically requires nail clipping or subungual scraping for KOH preparation and fungal culture (gold standard for onychomycosis), or nail biopsy (for inflammatory and genetic conditions). PCR-based nail testing has superior sensitivity to culture and provides results in 3–5 days versus the 4–6 weeks of traditional culture — we use PCR testing as our primary diagnostic tool for suspected onychomycosis.

Treatment Options by Cause

Fungal Nail Dystrophy (Onychomycosis)

Confirmed onychomycosis is treated with oral antifungals (terbinafine 250 mg daily for 12 weeks is gold standard, with 70–80% mycologic cure rates), topical antifungals (ciclopirox 8% lacquer or efinaconazole 10% solution for mild-moderate cases or patients who can’t tolerate oral medication), or laser therapy (1064 nm Nd:YAG — effective for photo-thermal destruction of fungal elements, no systemic side effects). Nail avulsion — removing the dystrophic plate to allow antifungal penetration and healthy regrowth — is recommended for severely thickened nails that won’t respond to topical agents alone. We monitor liver function for patients on terbinafine with baseline and follow-up labs.

Psoriatic Nail Dystrophy

Nail psoriasis treatment is coordinated with dermatology or rheumatology for patients with concurrent skin or joint disease. First-line options include potent topical corticosteroids and vitamin D analogues (calcipotriol) applied to the nail folds and subungual area. Intralesional triamcinolone injections into the nail matrix produce significant improvement in pitting and nail plate quality. Systemic biologics — TNF inhibitors, IL-17 inhibitors (secukinumab, ixekizumab), and IL-23 inhibitors — achieve the highest rates of nail clearance and are the treatment of choice for patients with systemic psoriasis or psoriatic arthritis requiring systemic therapy anyway.

Traumatic Nail Dystrophy

Treatment starts with eliminating the causative trauma: proper shoe sizing, padded socks, nail trimming technique correction, and activity modification. For runners, we specifically check for toe box compression and assess running shoe wear patterns. When the dystrophic nail is causing pain, partial or total nail avulsion under local anesthesia removes the damaged plate and allows the matrix to produce a new nail — typically 6–12 months for full regrowth. Chemical or surgical matrixectomy (permanent nail removal) is considered only when the dystrophy is severe, recurrent, and associated with chronic pain.

Lichen Planus and Inflammatory Conditions

Early aggressive treatment with intralesional or systemic corticosteroids is the priority for nail lichen planus — particularly in patients showing matrix involvement — to prevent irreversible pterygium formation. Hydroxychloroquine and retinoids are second-line systemic options. For eczematous nail dystrophy, removing contact allergens and applying potent topical steroids under occlusion to the nail folds addresses the inflammation. Alopecia areata-associated nail dystrophy often improves with treatment of the underlying autoimmune condition using JAK inhibitors (tofacitinib, ruxolitinib) — a rapidly growing evidence base as of 2024–2026.

Red Flags: When to See a Podiatrist

Most Common Mistake with Nail Dystrophy

The most common mistake is treating all nail dystrophy with OTC antifungal nail polish without confirming a fungal diagnosis. In our experience, fewer than half of patients who’ve been self-treating with antifungals for months actually have onychomycosis — many have psoriasis, traumatic dystrophy, or lichen planus. Antifungals do nothing for these conditions, and the months lost to ineffective treatment allow inflammatory conditions to cause permanent damage. Nail biopsy and culture add a few days to diagnosis and completely change treatment outcomes. We will always confirm the cause before prescribing — and we encourage patients to demand the same from any provider treating their nails.

In-Office Treatment at Balance Foot & Ankle

At Balance Foot & Ankle, our nail dystrophy workup includes PCR-based nail testing, clinical photography for monitoring, and same-visit nail avulsion when indicated. We offer oral and topical antifungal prescriptions, intralesional corticosteroid injections for psoriatic and lichen planus nail disease, and coordination with dermatology for systemic inflammatory cases. Dr. Tom Biernacki and our team provide comprehensive nail care at our Howell and Bloomfield Hills clinics. Call (810) 206-1402 or book online for a same-day appointment.

Can nail dystrophy be cured?

Yes, in most cases — if the underlying cause is identified and treated appropriately. Fungal nail dystrophy achieves mycologic cure in 70–80% with oral terbinafine. Traumatic dystrophy resolves when the trauma source is eliminated. Psoriatic nail dystrophy responds well to biologics in patients with systemic disease. Lichen planus with early matrix involvement can be reversed with aggressive treatment. Irreversible cases — late-stage lichen planus pterygium, severe matrix scarring — cannot restore nail growth.

How is nail dystrophy diagnosed?

Accurate diagnosis requires nail clipping for PCR or culture (fungal cases), nail biopsy (inflammatory or uncertain cases), systemic workup for blood markers (iron, thyroid, inflammatory markers) when systemic disease is suspected, and detailed history including medications, family history, and activity. Clinical appearance alone is insufficient — studies show appearance-based diagnosis of onychomycosis is wrong about half the time.

When should I see a podiatrist for nail dystrophy?

See a podiatrist if OTC treatments haven’t worked after 3 months, if the nail is painful or infected, if you have diabetes or peripheral vascular disease, or if you notice any dark streaks under the nail. At Balance Foot & Ankle, same-day appointments are available — call (810) 206-1402.

Does insurance cover nail dystrophy treatment?

Podiatric evaluation, nail biopsy, and prescription antifungals are covered by most insurance plans when medically indicated. Cosmetic nail procedures may not be covered. Systemic biologics for psoriatic nail disease typically require prior authorization. Our team handles insurance verification before your appointment.

Sources

1. Hay RJ. “Onychomycosis.” Journal of the American Academy of Dermatology. 2011;65(6):1219–1227.
2. Dogra S, et al. “Nail psoriasis: a review of the literature.” Indian Journal of Dermatology, Venereology and Leprology. 2012;78(4):412–422.
3. Tosti A, Piraccini BM. “Nail disorders.” In: Fitzpatrick’s Dermatology in General Medicine. 8th ed. 2012.
4. Grover C, Khurana A. “Nail lichen planus.” Indian Journal of Dermatology, Venereology and Leprology. 2012;78(3):263–268.
5. Gupta AK, et al. “New and emerging therapies for onychomycosis.” Dermatologic Clinics. 2024;42(3):421–433.
6. Armstrong AW, et al. “Nail psoriasis severity and biologic treatment outcomes.” Journal of Psoriasis and Psoriatic Arthritis. 2025;10(1):44–52.

How long does treatment take to work?

Most patients see improvement in 4-8 weeks with consistent conservative care. Persistent symptoms after 8 weeks need imaging and escalation.

When is surgery needed?

Surgery is reserved for cases that fail 3-6 months of conservative care, structural deformities, or fractures requiring stabilization.

Is this covered by insurance?

Most diagnostic visits and conservative treatments are covered by Medicare and major insurers. Custom orthotics often require diabetic or post-surgical justification.

Doctor Hoy’s Natural Pain Relief Gel

Natural topical pain relief I use in our clinic. Arnica + camphor formula — apply directly to the area 3–4x daily. ($20–25)

Shop Doctor Hoy’s →